OBJECTIVE: To test the hypothesis that abnormal hemorheology and chronic low-grade inflammation are more prevalent in Lewis negative individuals, possibly contributing to premature atherosclerosis. METHODS AND RESULTS: We enrolled 223 healthy subjects (154 females, mean age: 64yrs). Conventional risk factors, markers of inflammation and hemorheological profiles were measured; Lewis blood group was determined by serology. Conventional risk factors (age, gender, BMI, blood pressure, lipid profile, smoking habit) did not differ among Lewis phenotypes. However, markers of inflammation (WBC, hs-CRP, ESR) were significantly elevated and rheological parameters (RBC aggregation, plasma viscosity) were abnormal in Lewis negative subjects, especially when compared to the Le(a-b+) group. CONCLUSIONS: With a prevalence of 33% in select populations, our data support the hypothesis that Le(a-b-) represents a pro-inflammatory phenotype that may contribute to the elevated cardiovascular risk in this group.
OBJECTIVE: To test the hypothesis that abnormal hemorheology and chronic low-grade inflammation are more prevalent in Lewis negative individuals, possibly contributing to premature atherosclerosis. METHODS AND RESULTS: We enrolled 223 healthy subjects (154 females, mean age: 64yrs). Conventional risk factors, markers of inflammation and hemorheological profiles were measured; Lewis blood group was determined by serology. Conventional risk factors (age, gender, BMI, blood pressure, lipid profile, smoking habit) did not differ among Lewis phenotypes. However, markers of inflammation (WBC, hs-CRP, ESR) were significantly elevated and rheological parameters (RBC aggregation, plasma viscosity) were abnormal in Lewis negative subjects, especially when compared to the Le(a-b+) group. CONCLUSIONS: With a prevalence of 33% in select populations, our data support the hypothesis that Le(a-b-) represents a pro-inflammatory phenotype that may contribute to the elevated cardiovascular risk in this group.
Authors: Francis H Verbeke; Mohsen Agharazii; Pierre Boutouyrie; Bruno Pannier; Alain P Guérin; Gérard M London Journal: J Am Soc Nephrol Date: 2007-01-03 Impact factor: 10.121
Authors: V Salomaa; J Pankow; G Heiss; B Cakir; J H Eckfeldt; R C Ellison; R H Myers; K M Hiller; K R Brantley; T L Morris; B W Weston Journal: J Intern Med Date: 2000-06 Impact factor: 8.989
Authors: Howard N Hodis; Wendy J Mack; Laurie Dustin; Peter R Mahrer; Stanley P Azen; Robert Detrano; Jacob Selhub; Petar Alaupovic; Chao-ran Liu; Ci-hua Liu; Juliana Hwang; Alison G Wilcox; Robert H Selzer Journal: Stroke Date: 2008-12-31 Impact factor: 7.914